REVO Insurance SpA (MIL:REVO) Research & Development: €0.0 Mil (TTM As of Dec. 2025)


MIL:REVO REVO Insurance SpA MIL:REVO
81 GF Score
Price €25.45
GF Value €19.85
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is REVO Insurance SpA Research & Development?

REVO Insurance SpA MIL:REVO -0.97% 81 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates MIL:REVO with a GF Score™ of 81/100 and a GF Value™ of €19.85 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. REVO Insurance SpA's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

REVO Insurance SpA  (MIL:REVO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

REVO Insurance SpA Research & Development Related Terms

REVO Insurance SpA Research & Development Historical Data

* Premium members only.

The historical data trend for REVO Insurance SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

REVO Insurance SpA Research & Development Chart

REVO Insurance SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

REVO Insurance SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:REVO
81GF Score
REVO Insurance SpA MIL:REVO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

REVO Insurance SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
REVO Insurance SpA (MIL:REVO) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on REVO Insurance SpA and its competitors.
Is REVO Insurance SpA's Research & Development too high?
REVO Insurance SpA's current Research & Development is €0.0 Mil. Overall, REVO Insurance SpA has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does REVO Insurance SpA's Research & Development compare to CB and PGR?
REVO Insurance SpA's Research & Development of €0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on REVO Insurance SpA and its competitors. REVO Insurance SpA's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is REVO Insurance SpA stock overvalued right now?
Based on GuruFocus' analysis, REVO Insurance SpA (MIL:REVO) is currently considered Modestly Overvalued. The stock's GF Value™ is €19.85, compared to a current price of €25.45 — trading 28.2% above its estimated fair value. The current Research & Development is €0.0 Mil. REVO Insurance SpA's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For REVO Insurance SpA (MIL:REVO), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is REVO Insurance SpA (MIL:REVO) Overvalued in 2026?

Based on GuruFocus' analysis, REVO Insurance SpA stock appears to be overvalued. The current stock price of €25.45 is trading 28.2% above its estimated GF Value™ of €19.85. GuruFocus considers REVO Insurance SpA to be Modestly Overvalued.

Key valuation signals for MIL:REVO:

  • Research & Development: €0.0 Mil
  • GF Value™: €19.85 vs. price of €25.45 (28.2% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the MIL:REVO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

REVO Insurance SpA Business Description

Other Exchanges REVOm:UKH0O:Germany
Address Via Monte Rosa 91, Milan, ITA, 20149
REVO Insurance SpA is an insurance company based in Italy. It specializes in special and parametric risks and with a prevalent, as well as focus on the SME sector. It operates in the Non-life Operations segment, Life Operations segment, Equity interests, and others, and the majority of its revenue comes from the Non-life Operations segment.
81GF Score

Get the complete analysis for MIL:REVO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.45
Price
€19.85
GF Value